Overview

The actively managed fund invests globally in a diversified range of mainly high-quality bonds, equities as well as alternative investments, including hedge funds.

Investments are focused on bonds.

Foreign currencies are largely hedged versus the reference currency. Nevertheless, an active currency strategy is applied if opportunities are seen.

The fund is based on UBS's investment policy, the UBS House View.

The fund invests without any benchmark restrictions. The performance of the fund is not benchmarked against an index.

Benefits

The fund offers the investor straightforward and convenient access to UBS House View, which draws on the professional insights of UBS investment specialists worldwide.

The inclusion of alternative investments, including hedge fund investments optimises the portfolio's risk/return profile.

Investors benefit globally from diversified market opportunities in a wide variety of asset classes.

The weighting of the different asset classes is maintained within a specific range in order to take account of the fund's risk profile.

The fund is attractive for cautious investors who focus on interest and dividends, but who are also prepared to take on additional risks in order to generate capital gains.

Risks

The fund invests in bonds of varying credit quality, money market securities and equities on a global basis, as well as in alternative forms of investment such as hedge funds. It may therefore be subject to fluctuations in value. The fund may use derivatives which can reduce investment risk or give rise to additional risks (inter alia the counterparty risk). The fund can invest in less liquid assets that may be difficult to sell in the case of distressed markets. It therefore cannot be ruled out that the daily issue and redemption of fund units may be suspended temporarily. The value of a unit may fall below the purchase price. This requires an elevated risk tolerance and capacity. Every fund reveals specific risks, a description of these risks can be found in the prospectus.

Features

Product category
UBS Asset Allocation Funds
UBS Strategy Xtra Funds
Product domicile
Luxembourg
Portfolio management
UBS SA国际传谋 Switzerland AG, Zurich
Fund management
UBS SA国际传谋 (Europe) S.A., Luxembourg
Custodian bank
UBS Europe SE, Luxembourg Branch
Representative for products established under foreign law
BNP PARIBAS Securities Services
Day of inception
June 19, 2014
Currency of account
EUR
Close of financial year
May 31
SFDR Classification
Art.6
Issue / redemption
daily
Distribution
Reinvestment
Maturity
Open end
Ongoing costs p.a.
1.96% p.a.
Management fee
1.44% p.a.
Total expense ratio (TER)
1.93% p.a.
Swing pricing
yes
Minimum investment
n.a.
ISIN
LU1059709862
Bloomberg Ticker
UBXYLPA LX
Telekurs Id
n.a.

Performance and Prices

Percentage growth

as of April 23, 2026
Cumulative
EUR(%)
YTD 1.11
1M
3M
6M
1Y 9.62
2Y 12.77
3Y 17.51
5Y 6.95
ø p.a.5Y

Current data

Net asset value 23.04.2026 EUR 117.94
High - last 12 months 27.02.2026 EUR 119.10
Low - last 12 months 24.04.2025 EUR 108.11
Assets of the unit class in mn 23.04.2026 EUR 42.91
Total product assets in mn 23.04.2026 EUR 51.44
Theoretical yield to maturity (gross) 31.03.2026 4.97%
Modified duration 31.03.2026 2.62

Structures

By investment instrument and currency (in %, as of March 31, 2026)

 
Cash + Bonds
Equities
Alternative investments
Total
Total1)
AUD 0.00 -0.06 0.00 -0.06 0.66
CAD 0.01 -0.08 0.00 -0.07 -0.72
CHF 0.00 1.92 0.00 1.92 0.09
CNY 0.01 0.88 0.00 0.88 -0.12
CZK 0.01 0.00 0.00 0.01 0.01
EUR 19.48 13.01 0.00 32.49 95.38
GBP 3.22 1.36 0.00 4.58 0.02
HKD 0.00 0.01 0.00 0.01 -0.70
JPY 0.00 0.04 0.00 0.04 0.10
PLN 0.04 0.05 0.00 0.09 0.08
SGD 0.00 0.05 0.00 0.05 -0.80
USD 30.28 14.24 13.60 58.12 1.44
Others 0.20 1.74 0.00 1.94 4.57
Total 53.24 33.16 13.60 100.00 100.00

Fees

Ongoing costs p.a.
1.96%
Flat fee
1.80%
Management fee p.a.
1.44%
Max. issuing commission
4.00%
Max. redemption commission
0.00%
Distribution fee
(see info)

Distributions

No distributions. Continuous reinvestment of income.

Sales Authorisations

Market
Sales authorisations status
Austria
Registered
Belgium
Registered
Finland
Registered
France
Registered
Germany
Registered
Greece
Registered
Italy
Registered
Liechtenstein
Registered
Luxembourg
Registered
Netherlands
Registered
Singapore
Institutional Only*
Spain
Registered
Sweden
Registered
Switzerland
Registered
United Kingdom
Registered

Literature

Agreement / Prospectus
Document type
Document Language
Prospectus
Key Information Document
Past performance
Previous performance scenario
Annual and semi-annual report (accounting on May 31)
Document type
Document Language
Annual report
Semi-annual report
Please wait for the requested content to load. If there is no response after several minutes, please reload the page or try again later.